Identification and prospective stability of electronic nose (eNose)–derived inflammatory phenotypes in patients with severe asthma

[1]  T. J. Vink,et al.  Methodological considerations for large-scale breath analysis studies: lessons from the U-BIOPRED severe asthma project , 2018, Journal of breath research.

[2]  B. Hargadon,et al.  Airway pathological heterogeneity in asthma: Visualization of disease microclusters using topological data analysis , 2018, The Journal of allergy and clinical immunology.

[3]  P. Sterk,et al.  Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label , 2018, European Respiratory Journal.

[4]  H. Makita,et al.  Distinct Phenotypes of Smokers with Fixed Airflow Limitation Identified by Cluster Analysis of Severe Asthma , 2018, Annals of the American Thoracic Society.

[5]  R. Zenobi,et al.  Metabolic effects of inhaled salbutamol determined by exhaled breath analysis , 2017, Journal of breath research.

[6]  Mario Castro,et al.  Quantitative computed tomographic imaging–based clustering differentiates asthmatic subgroups with distinctive clinical phenotypes , 2017, The Journal of allergy and clinical immunology.

[7]  T. J. Vink,et al.  Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[8]  Naomi S. Altman,et al.  Points of Significance: Principal component analysis , 2017, Nature Methods.

[9]  C. Auffray,et al.  A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from U‐BIOPRED Cohorts , 2017, American journal of respiratory and critical care medicine.

[10]  Camille Roth,et al.  Natural Scales in Geographical Patterns , 2017, Scientific Reports.

[11]  P. Hellings,et al.  Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients , 2017, Respiratory Research.

[12]  C. Auffray,et al.  T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED , 2017, European Respiratory Journal.

[13]  Peter J Sterk,et al.  Breathomics in the setting of asthma and chronic obstructive pulmonary disease. , 2016, The Journal of allergy and clinical immunology.

[14]  E. Bel,et al.  Improving the diagnosis of eosinophilic asthma , 2016, Expert review of respiratory medicine.

[15]  Zhenyu Liang,et al.  A Systemic Inflammatory Endotype of Asthma With More Severe Disease Identified by Unbiased Clustering of the Serum Cytokine Profile , 2016, Medicine.

[16]  J. Martin,et al.  Phenotyping of difficult asthma using longitudinal physiological and biomarker measurements reveals significant differences in stability between clusters , 2016, BMC Pulmonary Medicine.

[17]  Ioannis Pandis,et al.  Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort , 2015, European Respiratory Journal.

[18]  Borislav D. Dimitrov,et al.  Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms , 2015, The Journal of allergy and clinical immunology.

[19]  A. Zwinderman,et al.  The prevalence of severe refractory asthma. , 2015, The Journal of allergy and clinical immunology.

[20]  W. Assendelft,et al.  Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care. , 2015, The Journal of allergy and clinical immunology.

[21]  M P van der Schee,et al.  Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis , 2014, Journal of breath research.

[22]  J. Merino,et al.  Inflammatory Asthma Phenotype Discrimination Using an Electronic Nose Breath Analyzer. , 2015, Journal of investigational allergology & clinical immunology.

[23]  C. Akdis,et al.  Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air , 2014, Respiratory Research.

[24]  R. Lutter,et al.  External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma , 2014, Thorax.

[25]  P. Chanez,et al.  Prognostic value of cluster analysis of severe asthma phenotypes. , 2014, The Journal of allergy and clinical immunology.

[26]  Catherine Bailey,et al.  Detection of Colorectal Cancer (CRC) by Urinary Volatile Organic Compound Analysis , 2014, PloS one.

[27]  I. Pavord,et al.  Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. , 2014, The New England journal of medicine.

[28]  P. Burton,et al.  Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability , 2014, PloS one.

[29]  W. Busse,et al.  Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. , 2014, The Journal of allergy and clinical immunology.

[30]  P. Woodruff,et al.  Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. , 2014, The Journal of allergy and clinical immunology.

[31]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[32]  P. Sterk,et al.  Alterations in exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury. , 2013, Journal of applied physiology.

[33]  J. Cowan,et al.  Predicting steroid responsiveness in patients with asthma using exhaled breath profiling , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[34]  Jill P Mesirov,et al.  Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration , 2013, BMC Medicine.

[35]  A. Zwinderman,et al.  Severe adult-onset asthma: A distinct phenotype. , 2013, The Journal of allergy and clinical immunology.

[36]  Charles Auffray,et al.  Application of ’omics technologies to biomarker discovery in inflammatory lung diseases , 2013, European Respiratory Journal.

[37]  T. J. Vink,et al.  Effect of transportation and storage using sorbent tubes of exhaled breath samples on diagnostic accuracy of electronic nose analysis , 2012, Journal of breath research.

[38]  Ashley Woodcock,et al.  Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study , 2012, Respiratory Research.

[39]  S. Holgate.  Asthma: a simple concept but in reality a complex disease , 2011, European journal of clinical investigation.

[40]  Ashley Woodcock,et al.  Non-invasive phenotyping using exhaled volatile organic compounds in asthma , 2011, Thorax.

[41]  F H Krouwels,et al.  Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD , 2011, European Respiratory Journal.

[42]  J. Beauchamp,et al.  Inhaled today, not gone tomorrow: pharmacokinetics and environmental exposure of volatiles in exhaled breath , 2011, Journal of breath research.

[43]  Jodie L Simpson,et al.  Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. , 2011, The Journal of allergy and clinical immunology.

[44]  Peter J Sterk,et al.  Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI) , 2010, Thorax.

[45]  A. Chang,et al.  A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils) , 2010, Thorax.

[46]  Charles Auffray,et al.  An integrative systems biology approach to understanding pulmonary diseases. , 2010, Chest.

[47]  Giorgio Pennazza,et al.  Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. , 2010, Chest.

[48]  D. Curran‐Everett,et al.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010, American journal of respiratory and critical care medicine.

[49]  Niki Fens,et al.  Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. , 2009, American journal of respiratory and critical care medicine.

[50]  Barmak Modrek,et al.  T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.

[51]  Heng Tao Shen,et al.  Principal Component Analysis , 2009, Encyclopedia of Biometrics.

[52]  K. R. Clarke,et al.  Testing of null hypotheses in exploratory community analyses: similarity profiles and biota-environment linkage , 2008 .

[53]  I. Pavord,et al.  A new perspective on concepts of asthma severity and control , 2008, European Respiratory Journal.

[54]  Peter J Sterk,et al.  An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.

[55]  R. Paolesse,et al.  Metalloporphyrins based artificial olfactory receptors , 2007 .

[56]  A. Chang,et al.  Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. , 2007, The Cochrane database of systematic reviews.

[57]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[58]  R. A. van den Berg,et al.  Centering, scaling, and transformations: improving the biological information content of metabolomics data , 2006, BMC Genomics.

[59]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[60]  Klas Svensson,et al.  Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. , 2005, Respiratory medicine.

[61]  ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. , 2005, American journal of respiratory and critical care medicine.

[62]  N. Lewis.  Comparisons between mammalian and artificial olfaction based on arrays of carbon black-polymer composite vapor detectors. , 2004, Accounts of chemical research.

[63]  P. Sterk,et al.  Sputum induction , 2002, European Respiratory Journal.

[64]  J. Piccirillo,et al.  Psychometric and Clinimetric Validity of the 20-Item Sino-Nasal Outcome Test (Snot-20) , 2002, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[65]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[66]  Paul Golder,et al.  The Guttman-Kaiser Criterion as a Predictor of the Number of Common Factors , 1982 .

[67]  D. Cox,et al.  An Analysis of Transformations , 1964 .